VR Logo

Opiant Pharmaceuticals Inc. (OPNT) download report


Healthcare | Biotechnology & Pharma Research

Opiant Pharmaceuticals Inc. (OPNT) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.

IPO Date: 04-Jan-2016

Pres, CEO & Director: Dr. Roger Crystal M.D.

Chief Financial Officer: Mr. David D. O'Toole

Listing: NASDAQ: OPNT

Country: United States

Headquarters: Santa Monica, CA

Website: https://www.opiant.com

Key Facts

Market cap: $55.75 Mln

Revenue (TTM): $15.99 Mln

Earnings (TTM): $-8.02 Mln

Cash: $50.83 Mln

Total Debt: $14.55 Mln

Insider's Holding: 6.91%

Liquidity: Low

52 Week range: $7.34 - 37.71

Shares outstanding: 5,087,020

10 Years Aggregate:

  • CFO: $26.79 Mln
  • EBITDA: $-21.09 Mln
  • Net Profit: $-38.74 Mln

Stock Performance

Time Period Opiant Pharmaceuticals (OPNT) S&P BSE Sensex S&P Small-Cap 600
YTD-62.41-9.49-17.79
1 month-7.80-2.87-2.72
3 months-42.52-8.59-12.17
1 Year-8.930.81-15.82
3 Years-3.3010.397.14
5 Years18.2411.116.20
10 Years2.4712.0010.33
As on 24-Jun-2022
Year Opiant Pharmaceuticals (OPNT) S&P Small-Cap 600 S&P BSE Sensex
2021318.8025.2721.99
2020-44.249.5715.75
2019-0.3520.8614.38
2018-36.93-9.705.87
2017309.4511.7327.91
2016-43.0524.741.95
201594.69-3.36-5.03